1-Ethyl-3-methylimidazolium triflate, 98.0%, 100g

Methyl 2-bromo-3-(benzyloxy)-6-fluorobenzoate, 98%, 1g

(2E)-1-(2,4-dimethoxyphenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

6-Bromoisoindolin-1-one, 95.0%, 5g

Solución de sal disódica de EDTA, volumen ROTI® 0,01 mol/l - 0,01 N, ampolla, 1 pieza

DEPC, 5 ml, vidrio

5-Acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine, 95.0%, 100g

1-Boc-4-(2-Carboxyphenyl)piperazine, 95.0%, 5g

1-(4-Methoxyphenyl)-5-methyl-1H-pyrazole-3-carboxylic acid, 1g

7-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indole-6-carbonitrile, 97%, 250mg

Arachidonic acid, >99%, 10g

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate, 98%, 1g

7-Bromothieno[3,2-d]pyrimidin-4-amine, 95.0%, 250mg